Gilead Sciences Dividends
| GILD Stock | USD 92.41 1.06 1.16% |
As of November 28, 2024, Dividends Paid is expected to decline to about 3.4 B. In addition to that, Dividend Yield is expected to decline to 0.03. Gilead Sciences' past performance could be the main factor of why investors trade Gilead Sciences stock today. Investors should clearly understand every aspect of the Gilead Sciences dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Gilead Sciences' dividend schedule and payout information. Gilead Sciences dividends can also provide a clue to the current valuation of Gilead Sciences.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 3.8 B | 3.4 B | |
| Dividend Yield | 0.04 | 0.03 | |
| Dividend Payout Ratio | 0.67 | 0.64 | |
| Dividend Paid And Capex Coverage Ratio | 1.82 | 1.73 |
Gilead |
Investing in dividend-paying stocks, such as Gilead Sciences is one of the few strategies that are good for long-term investment. Ex-dividend dates are significant because investors in Gilead Sciences must own a stock before its ex-dividend date to receive its next dividend.
Gilead Sciences Dividends Paid Over Time
Today, most investors in Gilead Sciences Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Gilead Sciences' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's dividends paid growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Gilead Sciences dividends paid as a starting point in their analysis.
The total amount of dividends that a company has paid out to its shareholders over a specific period. Dividends Paid |
| Timeline |
Gilead Sciences Historical Dividend Yield Growth
A solid dividend growth pattern of Gilead Sciences could indicate future dividend growth is likely, which can signal long-term profitability for Gilead Sciences. When investors calculate the dividend yield growth rate, they can use any interval of time they wish. They may also calculate the dividend yield growth rate using the least-squares method or simply take an annualized figure over a given time period. Dividend Yield is Gilead Sciences dividend as a percentage of Gilead Sciences stock price. Gilead Sciences dividend yield is a measure of Gilead Sciences stock productivity, which can be interpreted as interest rate earned on an Gilead Sciences investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share. Dividend Yield |
| Timeline |
Recent Gilead Sciences Dividends Paid (per share)
Dividends Paid |
| Timeline |
Gilead Sciences Expected Dividend Income Per Share
Dividend payment represents part of Gilead Sciences' profit that is distributed to its stockholders. It is considered income for that tax year rather than a capital gain. In other words, a dividend is a prize given to shareholders for investing in Gilead Sciences. Gilead Sciences' board of directors can pay out dividends at a planned frequency, such as monthly or quarterly.
$2.19 Bottom Scenario | $2.26 | $2.34 Top Scenario |
One Year
Gilead Sciences expected dividend income per share adjusted for ongoing price standard deviation
Gilead Sciences Past Distributions to stockholders
| 27th of September 2024 | ||
| 27th of June 2024 | ||
| 28th of March 2024 | ||
| 28th of December 2023 | ||
| 15th of December 2023 | ||
| 28th of September 2023 | ||
| 29th of June 2023 | ||
| 30th of March 2023 | ||
| 29th of December 2022 |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Gilead Sciences. If investors know Gilead will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Gilead Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.42) | Dividend Share 3.06 | Earnings Share 0.09 | Revenue Per Share 22.703 | Quarterly Revenue Growth 0.07 |
The market value of Gilead Sciences is measured differently than its book value, which is the value of Gilead that is recorded on the company's balance sheet. Investors also form their own opinion of Gilead Sciences' value that differs from its market value or its book value, called intrinsic value, which is Gilead Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Gilead Sciences' market value can be influenced by many factors that don't directly affect Gilead Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Gilead Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Gilead Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Gilead Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.